News Focus
News Focus
icon url

north40000

02/27/26 8:30 PM

#446361 RE: TastyTheElf #446360

CaptBeer’s charts re “Fenofibrate switchover” tell  a more encouraging story. Btw, what can you tell us about government embargo’s against specific products under U.S. trade laws after last Friday’s Supreme Court (170 pages total read) decision on tariffs/taxes/duties? Might 1)public safety + 2)fraud in obtaining a generic label in the process of FDA label negotiations be factors favoring an embargo against a pair of generics here? Trump placed/delegated V.P. Pence to be in charge of Medicare fraud about an hour into his State of Union address. The Secretary of Commerce is still in Office. An embargo against a specific product under U.S. trade laws prevents importation of that product.
icon url

SovereignNinja5

02/28/26 6:32 AM

#446365 RE: TastyTheElf #446360

Science is hard for many on here. I get it. Practicing medicine is even harder and regulatory science is not science. We don’t even have to discuss how PBM’s work and why. Other than that this group is well versed in all things about Amarin and the space it operates in. 
China was explained by Berg already. Remember, him and Burrows put up a hostage video on their website you can still view. Turns out it was slightly different than what they were stating. Oops. 🙊 

Without a CSG the mushroom club on here, ST and YF will continue arguing in circles about the SCOTUS infringement and anti trust case and we can hear about FFS charts, volume with Benfine  and people going on vacation or even better sports and 60 minutes reruns. One of you will call Olshan law. Hearing it for yourselves will be eye opening. 
If nothing changes, nothing changes. Enjoy the weekend cocktails and avoid hangovers. I’m pretty sure talking with a law firm for 10 minutes that specializes in a CSG for retail shareholders is better than voo doo that you’re suggesting. Cheers!